Leveraging biologics manufacturing capacity to supply life-improving or life-saving medicines is key to a flexible supply chain that can respond to unforeseen demand changes. This webinar examines how a globally harmonized CDMO operating model can support rapid technology transfer and production across a standardized network. However, the constantly evolving landscape driven by scientific and technological advances requires adaptability and innovative solutions within this standardized framework.
The featured speakers will outline how a continuous processing platform and a perfusion-ready cell line fit into a standardized approach for integrating connected batch and continuous processing strategies into greenfield single-use facilities. The advent of continuous biomanufacturing within a modular, multi-product ecosystem can provide greater flexibility and supply options to meet current and future patient needs.
Register for this webinar to learn how biologics manufacturing can incorporate connected batch and continuous processing to improve flexibility, utilization and supply options.
Speaker
Charles Heise, Associate Director, FUJIFILM Biotechnologies
Charles Heise is an Associate Director in the Bioprocessing Strategy & Development group at FUJIFILM Biotechnologies, developing connected, integrated processes. He has over 20 years of experience in the biologics industry, leading the development of cGMP processes for clinical and commercial recombinant protein manufacture and academic research collaborations. He is co-inventor of the award-winning SymphonX™ purification skid and the downstream technical lead for Fujifilm’s continuous biomanufacturing platform, , MaruX™. Charles graduated from the University of Oxford in the UK and earned his doctorate from the University of York.
Message PresenterWho Should Attend?
This webinar will appeal to:
- CTO, COO, Senior Technical Leaders and Senior Operations Leaders
- Facility Managers, Heads of Science, Heads of Process Development and MSAT
- Process intensification, continuous biomanufacturing and modular facility design professionals
What You Will Learn
Attendees will gain insight into:
- How integrated, connected batch and continuous processing at manufacturing scales is a reality
- The ways multi-drug facilities have the flexibility and modularity from the facility shell all the way to the production line
- How robust, disposable plastic flow paths deliver single-use contamination control and fast turnaround alongside greater utilisation rates of multi-use equipment to enhance cost control and sustainability
Xtalks Partner
FUJIFILM Biotechnologies
FUJIFILM Biotechnologies, a subsidiary of FUJIFILM Corporation, is a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines and advanced therapies. With over 30 years of experience, the Company specializes in developing and manufacturing biopharmaceuticals using microbial, mammalian, and host/virus systems. With over 4,800 employees, FUJIFILM Biotechnologies operates a fully integrated, kojoX™ global network with major facilities in the United States, the United Kingdom, and Denmark, with a new site in Holly Springs, North Carolina, USA. The Company’s kojoX™ manufacturing network ensures supply chain agility for its customers through modular facilities and standardized processes for seamless scaling and technology transfers. FUJIFILM Biotechnologies offers comprehensive services, ranging from proprietary cell line development, to process and analytical development, and through to clinical and commercial manufacturing.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account